Skip to main content

US ClosedU.S. Closed

HRTX: Heron Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements.

52W Range

2ndpctl

Volume

0.29×avg

Market Cap

61.82MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Heron Therapeutics, Inc.

HRTXNASDAQ Capital Market·USD·Closed

Heron Therapeutics, Inc.

HRTXNASDAQ·USD·Closed

$0.33

−1.66%

$0.33

−$0.01 (1.66%)

52W Range

2ndpctl

Volume

0.29×avg

Mkt Cap

61.82MUSD

P/E

-1.7TTM

Div Yield

–ann